Laurence A. Rubin
Chief Executive Officer at Ellipsis Neurotherapeutics, Inc.
Profile
Laurence A.
Rubin is currently the Chief Executive Officer at Ellipsis Neurotherapeutics, Inc. and also serves as a Director at Weizmann Canada.
Previously, he held the position of Chief Executive Officer at Ellipsis Biotherapeutics Corp.
and was a Professor at the University of Toronto.
Laurence A. Rubin active positions
| Companies | Position | Start |
|---|---|---|
Ellipsis Neurotherapeutics, Inc.
 Ellipsis Neurotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ellipsis Neurotherapeutics, Inc. develops pharmaceutical products for treatment and preventing of Alzheimer's disease and related disorders. The firm commercializes neurodegenerative disease therapeutics and diagnostics. The company was founded by Laurence Rubin in November 2004 and is headquartered in Toronto, Canada. | Chief Executive Officer | 2004-10-31 |
Weizmann Canada
 Weizmann Canada Miscellaneous Commercial ServicesCommercial Services Weizmann Canada operates as a worldwide network of supporting organizations for the Weizmann Institute of Science. The company was founded in 1964 and is headquartered in Calgary, Canada. | Director/Board Member | - |
Former positions of Laurence A. Rubin
| Companies | Position | End |
|---|---|---|
Ellipsis Biotherapeutics Corp.
 Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | President | - |
| University of Toronto | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Ellipsis Neurotherapeutics, Inc.
Ellipsis Neurotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ellipsis Neurotherapeutics, Inc. develops pharmaceutical products for treatment and preventing of Alzheimer's disease and related disorders. The firm commercializes neurodegenerative disease therapeutics and diagnostics. The company was founded by Laurence Rubin in November 2004 and is headquartered in Toronto, Canada. | Health Technology |
Ellipsis Biotherapeutics Corp.
Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | Commercial Services |
Weizmann Canada
Weizmann Canada Miscellaneous Commercial ServicesCommercial Services Weizmann Canada operates as a worldwide network of supporting organizations for the Weizmann Institute of Science. The company was founded in 1964 and is headquartered in Calgary, Canada. | Commercial Services |
- Stock Market
- Insiders
- Laurence A. Rubin
